Actively Recruiting
Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
Led by Mayo Clinic · Updated on 2025-10-16
26
Participants Needed
1
Research Sites
162 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).
CONDITIONS
Official Title
Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients enrolled in the Pain Rehabilitation Center for opioid cessation, with or without esophageal symptoms.
You will not qualify if you...
- Inability to provide informed consent.
- Patients with previous gastroesophageal surgery or pneumatic dilation.
- Esophageal botulinum toxin injection within the prior 12 months.
- Esophageal stricture
- Achalasia types I and II
- Allergy to Lidocaine or other local anesthetics
- Subjects on anticoagulation
- Bilateral nasal obstruction
- Pregnancy or breast feeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic Minnesota
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
M
Mariah Robran
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here